Chebulagic Acid Synergizes the Cytotoxicity of Doxorubicin in Human Hepatocellular Carcinoma Through COX-2 Dependant Modulation of MDR-1

Publisher： Bentham Science Publishers

E-ISSN： 1875-6638|7|5|432-442

ISSN： 1573-4064

Source： Medicinal Chemistry, Vol.7, Iss.5, 2011-09, pp. : 432-442

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recombinant lipoproteins reinforce cytotoxicity of doxorubicin to hepatocellular carcinoma

By Wang Baolong Yuan Yuan Han Lei Ye Li Shi Xunlong Feng Meiqing

Journal of Drug Targeting, Vol. 22, Iss. 1, 2014-01 ,pp. : 76-85

Informa Healthcare

Access to resources Recommend Favorite

Effects on hepatocellular carcinoma of doxorubicin-loaded immunoliposomes designed to target the VEGFR-2

By Roth Patrik Hammer Caroline Piguet Anne-Christine Ledermann Monika Dufour Jean-François Waelti Ernst

Journal of Drug Targeting, Vol. 15, Iss. 9, 2007-11 ,pp. : 623-631

Informa Healthcare

Access to resources Recommend Favorite

Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines

By van der Sandt I.C.J. Blom-Roosemalen M.C.M. de Boer A.G. Breimer D.D.

European Journal of Pharmaceutical Sciences, Vol. 11, Iss. 3, 2000-09 ,pp. : 207-214

Elsevier

Access to resources Recommend Favorite

The Role of the Transcription Factor E2F1 in Hepatocellular Carcinoma

Current Drug Delivery, Vol. 14, Iss. 2, 2017-02 ,pp. : 272-281

Bentham Science Publishers

Access to resources Recommend Favorite

Gemcitabine cytotoxicity of human malignant glioma cells: modulation by antioxidants, BCL-2 and dexamethasone

By Rieger J. Durka S. Streffer J. Dichgans J. Weller M.

European Journal of Pharmacology, Vol. 365, Iss. 2, 1999-01 ,pp. : 301-308

Elsevier

Access to resources Recommend Favorite